Loading Video...
NTHRYS
Arrow

PGx in Psychiatry — Antidepressants, Antipsychotics & TDM Training | PGx, Response & Monitoring

NTHRYS >> Services >> Academic Services >> Training Programs >> Bioinformatics Training >> Pharmacogenomics, Pharmacometrics & Precision Therapeutics >> PGx in Psychiatry — Antidepressants, Antipsychotics & TDM Training | PGx, Response & Monitoring

PGx in Psychiatry — Antidepressants Antipsychotics & TDM — Hands-on

Link pharmacogenomic concepts with real world psychiatry decisions. This module focuses on antidepressants, antipsychotics and the role of therapeutic drug monitoring (TDM) , helping you structure PGx informed choices and monitoring plans for depression, anxiety and psychosis care pathways.

PGx in Psychiatry — Antidepressants Antipsychotics and TDM
Help Desk · WhatsApp
Session 1
Fee: Rs 8800
Psychiatry PGx Foundations & Pathways
  • Where PGx fits in depression, anxiety and psychosis care
  • treatment resistance themes early intolerability and side effects polypharmacy in long term care
  • ADME pathways relevant to psychotropics (conceptual)
  • hepatic metabolism and clearance transport and blood–brain barrier themes half life and steady state thinking
  • Outcomes of interest in psychiatry PGx
  • response and remission rates activation, sedation and weight gain adherence and relapse prevention
Session 2
Fee: Rs 11800
Antidepressants, Response Variability & PGx
  • Concepts around antidepressant exposure and response
  • once daily vs divided dosing themes time to steady state and washout titration and cross taper ideas
  • Gene–drug concepts for antidepressants (conceptual)
  • metabolic phenotype and exposure early side effects vs non response patterns when PGx can inform selection or dose bands
  • Case style themes: switching, augmentation and monitoring
  • insufficient response with side effects combination regimens conceptually role of follow up and counselling
Session 3
Fee: Rs 14800
Antipsychotics, Side Effects & PGx
  • Exposure linked side effect themes for antipsychotics
  • sedation and cognitive slowing metabolic changes conceptually movement symptom themes
  • PGx related concepts for antipsychotic exposure variation
  • metabolic phenotype and concentration polypharmacy and interaction ideas vulnerable patient subgroups
  • Structuring antipsychotic PGx considerations in notes
  • baseline and follow up monitoring lists communication with carers and team link to long term risk management
Session 4
Fee: Rs 18800
TDM, PGx & Mini Caseboard
  • Where therapeutic drug monitoring adds value in psychiatry
  • links between trough levels and exposure adherence and interaction checks combining TDM with PGx insights
  • Worked case: antidepressant or antipsychotic with PGx and TDM
  • summarize clinical context interpret conceptual level concentration outline monitoring and follow up plan
  • Deliverables: psychiatry PGx–TDM clinic note and slide
  • PDF or PPTX ready for case conferences template for future PGx consults


PDF